Histopathologic Tumor Response Following Neoadjuvant Hyperthermic Isolated Limb Perfusion in Extremity Soft Tissue Sarcomas, the Prognostic Value of the European Organization for Research and Treatment of Cancer: Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) Response Score

被引：0
|
作者：
Stevenson, M. G. [1 ]
Hoekstra, H. [1 ]
Song, W. [2 ]
Been, L. B. [1 ]
Suurmeijer, A. J. [2 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PF152
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 41 条
  • [21] Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072
    Benson, C.
    Ray-Coquard, I.
    Sleijfer, S.
    Litiere, S.
    Blay, J. -Y.
    Le Cesne, A.
    Papai, Z.
    Judson, I.
    Schoffski, P.
    Chawla, S.
    Gil, T.
    Piperno-Neumann, S.
    Marreaud, S.
    Dewji, M. R.
    van der Graaf, W. T. A.
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 89 - 94
  • [22] Activity of cribulin mesylate (E7389) in patients with soft tissue sarcoma (STS): Phase II studies of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC 62052).
    Schoffski, P.
    Ray-Coquard, I. L.
    Cioffi, A.
    Bin Bui, N.
    Bauer, S.
    Hartmann, J. T.
    Sciot, R.
    Wanders, J.
    Druyts, D.
    Hohenberger, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
    N Penel
    M V Glabbeke
    S Mathoulin-Pelissier
    I Judson
    S Sleijfer
    B Bui
    P Schoffski
    M Ouali
    S Marreaud
    V Brouste
    A Duhamel
    P Hohenberger
    J-Y Blay
    British Journal of Cancer, 2011, 104 : 1544 - 1550
  • [24] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in patients with locally advanced soft tissue sarcomas:: Treatment response and clinical outcome related to changes in proliferation and apoptosis
    Plaat, BEC
    Molenaar, WM
    Mastik, MF
    Koudstaal, J
    van den Berg, E
    Koops, HS
    Hoekstra, HJ
    CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1650 - 1657
  • [25] Surgical treatment of lung metastases - The European organization for research and treatment of cancer-soft tissue and bone sarcoma group study of 255 patients
    vanGeel, AN
    Pastorino, U
    Jauch, KW
    Judson, IR
    vanCoevorden, F
    Buesa, JM
    Nielsen, OS
    Boudinet, A
    Tursz, T
    Schmitz, PIM
    CANCER, 1996, 77 (04) : 675 - 682
  • [26] ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP
    BRAMWELL, V
    ROUESSE, J
    STEWARD, W
    SANTORO, A
    SCHRAFFORDTKOOPS, H
    BUESA, J
    RUKA, W
    PRIARIO, J
    WAGENER, T
    BURGERS, M
    VANUNNIK, J
    CONTESSO, G
    THOMAS, D
    VANGLABBEKE, M
    MARKHAM, D
    PINEDO, H
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1137 - 1149
  • [27] DOXORUBICIN VERSUS CYVADIC VERSUS DOXORUBICIN PLUS IFOSFAMIDE IN FIRST-LINE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED STUDY OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER SOFT-TISSUE AND BONE SARCOMA GROUP
    SANTORO, A
    TURSZ, T
    MOURIDSEN, H
    VERWEIJ, J
    STEWARD, W
    SOMERS, R
    BUESA, J
    CASALI, P
    SPOONER, D
    RANKIN, E
    KIRKPATRICK, A
    VANGLABBEKE, M
    VANOOSTEROM, A
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1537 - 1545
  • [28] Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
    Sleijfer, Stefan
    Ray-Coquard, Isabelle
    Papai, Zsuzsa
    Le Cesne, Axel
    Scurr, Michelle
    Schoeffski, Patrick
    Collin, Francoise
    Pandite, Lini
    Marreaud, Sandrine
    De Brauwer, Annick
    van Glabbeke, Martine
    Verweij, Jaap
    Blay, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3126 - 3132
  • [29] L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer
    van Ginkel, RJ
    Kole, AC
    Nieweg, OE
    Molenaar, WM
    Pruim, J
    Koops, HS
    Vaalburg, W
    Hoekstra, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (02) : 262 - 267
  • [30] Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study
    Young, Robin J.
    Litiere, Saskia
    Lia, Michela
    Hogendoorn, Pancras C. W.
    Fisher, Cyril
    Mechtersheimer, Gunhild
    Daugaard, Soren
    Sciot, Raf
    Collin, Francoise
    Messiou, Christina
    Gruenwald, Viktor
    Gronchi, Alessandro
    van der Graaf, Winette
    Wardelmann, Eva
    Judson, Ian
    ACTA ONCOLOGICA, 2017, 56 (07) : 1013 - 1020
12345